HARROW, INC.

HROWNasdaq· Pharmaceutical Preparations

Price History

Revenue

$272.3M

▲ 36.4% YoY

Net Income

-$5.1M

▲ 70.6% YoY

EPS

$-0.14

▲ 71.4% YoY

Cash

$72.9M

▲ 54.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.